Egypts Alzheimers Disease drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Excessive neuronal degeneration in adulthood is called Alzheimers disease or senile dementia and is distinguished from the normal changes in aging. It is the most common type of Dementia worldwide. It rapidly increases with aging, especially over 70 years. It is a progressive disease that results in the death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes.

The proportion of elderly in the middle east is projected to rise with the enhancement of the health care services in the area. The forecast is that in 3540 years, the young crowds will work their way up the population pyramid, and the elderly population in the Middle East will increase. Egypts elderly population will constitute about 7% of its total population and the experience of Alzheimers in the country is surrounded by misconceptions it is usually seen simply as the memory loss experienced when people get old. As of 2016, there were 14929 deaths 355 367 prevalent cases, and 218670 DALYs in Egypt.



Market Drivers

According to the latest WHO data published in 2018, Alzheimer & Dementia Deaths in Egypt reached 17,957 or 3.23% of total deaths. The age-adjusted Death Rate is 36.09 per 100,000 of the population, ranking Egypt at 29th in the world. The growing geriatric population is likely to increase the incidence of dementia and Alzheimer's. These factors will be responsible for the growth of the Alzheimers Drug market in Egypt.

On the other hand, growing demand for personalized drugs and affordable diagnostics tests will further boost various opportunities that will lead to the growth of the Alzheimers disease treatment market in the above-mentioned forecast period.

Limited awareness in the developing regions about the disease will restrain the growth of the Alzheimers disease treatment market in the forecast period of 2019-2028.